Xifaxan at a glance
Xifaxan is a brand of the antibiotic rifaximin, a medicine that works mainly within the gastrointestinal tract. It is used for selected bowel-related conditions when a clinician considers it appropriate. Availability, approved indications, and dispensing requirements should always be checked with a licensed pharmacy in Sweden.
Unlike antibiotics that circulate widely through the body, rifaximin is minimally absorbed from the gut in most people. This local action is clinically relevant because the medicine is intended to affect susceptible intestinal bacteria. It should not be viewed as a general treatment for every type of diarrhoea or abdominal discomfort.
A careful assessment is important before treatment begins. Symptoms such as fever, blood in stools, dehydration, severe pain, or persistent vomiting may require urgent medical evaluation rather than self-treatment. A pharmacist or prescriber can help determine whether Xifaxan is suitable.
What Xifaxan is used for
Rifaximin may be prescribed for specific gastrointestinal infections and, in some jurisdictions, for conditions involving altered intestinal bacterial activity. Its authorised uses differ by country, product strength, and formulation. Swedish patients should rely on the indication stated by their prescriber and the supplied patient information leaflet.
In some clinical settings, rifaximin is used to reduce recurrence of overt hepatic encephalopathy in adults with liver disease. It may also be considered for certain diarrhoeal illnesses where susceptible non-invasive bacteria are suspected. These uses require individual clinical judgment and are not interchangeable.
Antibiotics do not treat viral gastroenteritis, and unnecessary use can contribute to antimicrobial resistance. A diagnosis matters particularly when diarrhoea is prolonged, follows recent antibiotic use, or occurs after travel. Do not share leftover Xifaxan with another person.
Active ingredient and medicine development
The active ingredient in Xifaxan is rifaximin, a rifamycin-derived antibacterial medicine. Rifaximin was developed from the rifamycin class to provide antibacterial activity concentrated in the intestine. Its limited systemic absorption distinguishes it from several other antibiotics in the same broader family.
Rifamycin compounds originated from research into naturally occurring substances produced by microorganisms. Subsequent pharmaceutical development created semi-synthetic derivatives with different absorption patterns and clinical roles. Rifaximin was designed to remain predominantly in the gut after oral administration.
Modern use of rifaximin is supported by controlled clinical research and post-marketing safety monitoring. Evidence is interpreted according to the condition being treated, the dose, and the patient population. A product name alone does not establish that a particular indication is appropriate for an individual.
How rifaximin works
Rifaximin inhibits bacterial RNA synthesis by binding to a bacterial enzyme involved in transcription. Without normal RNA production, susceptible bacteria cannot maintain essential functions or multiply effectively. This mechanism is antibacterial rather than pain-relieving or anti-inflammatory.
Because relatively little rifaximin usually enters the bloodstream, its principal activity occurs in the intestinal lumen. The degree of benefit depends on the underlying condition and the sensitivity of relevant bacteria. It may not be effective against invasive infections or organisms that are resistant.
The medicine does not immediately restore bowel function in every case. Improvement may take time, and symptoms can worsen for reasons unrelated to treatment response. Patients should follow the review plan given by their healthcare professional.
Forms and strengths
Xifaxan is supplied as oral tablets in strengths that vary between markets. The available presentation, pack size, and authorised use may differ within Sweden depending on the licensed product and supply channel. A pharmacist can confirm the strength shown on a valid prescription.
Different rifaximin regimens are used for different medical conditions. The tablet strength should never be used to infer a dosing schedule without professional instructions. Taking more tablets than prescribed does not make an antibiotic work faster.
| Product detail | Why it matters |
|---|---|
| Tablet strength | Supports accurate dispensing and dose verification. |
| Pack size | Should correspond with the intended treatment duration. |
| Brand or generic status | May affect availability, appearance, and cost, while the active ingredient may be the same. |
Always check the medicine name, strength, expiry date, and patient label before use. Contact the dispensing pharmacy if the packaging differs from what was expected. Do not substitute or combine products unless a pharmacist or prescriber confirms it is appropriate.
How to take Xifaxan safely
Take Xifaxan exactly as directed on the prescription label or by the prescriber. It can generally be taken with or without food, unless individual instructions state otherwise. Swallow tablets with water and try to take doses at consistent times.
If a dose is missed, follow the advice in the patient leaflet or ask a pharmacist. In general, a missed dose should not lead to doubling the next dose. A regular schedule helps maintain the intended treatment exposure.
Complete the prescribed course unless a clinician tells you to stop. Stopping early may leave the underlying problem insufficiently treated, while continuing unnecessarily may raise the risk of adverse effects. Seek advice promptly if symptoms become more severe during treatment.
Expected onset and duration of effect
The timing of symptom improvement depends on why rifaximin was prescribed. Some people may notice a change within a few days, while others require assessment over the full planned course. Lack of improvement should be discussed rather than managed by changing the dose independently.
Rifaximin’s antibacterial activity is linked to its presence in the gut and to the treatment schedule. Its practical effect is therefore not usefully described as a fixed number of hours for every patient. The intended clinical benefit may continue to be assessed after the final tablet.
For recurring conditions, treatment objectives may include reducing episodes over a longer period rather than producing immediate relief. Follow-up is especially important for people with significant liver disease or ongoing bowel symptoms. Persistent symptoms can have causes that need separate investigation.
How long rifaximin remains in the body
Most orally administered rifaximin remains in the digestive tract and is eliminated largely through faeces. Only a small proportion is typically absorbed into the circulation in people with normal gastrointestinal function. This means that blood-level calculations used for many medicines are less informative for rifaximin.
Elimination can vary with liver function, intestinal disease, dose, and individual physiology. In people with severe liver impairment, systemic exposure may be higher than expected. Prescribers may therefore consider medical history carefully before starting treatment.
A pharmacist cannot determine an exact clearance time for one person without clinical context. Do not use estimates about elimination to decide when to restart, stop, or combine medicines. Ask the prescriber if timing is important for a planned procedure or another treatment.
Scientific evidence and treatment limits
Clinical studies have evaluated rifaximin for selected gastrointestinal and liver-related indications. Research generally examines defined patient groups, specified doses, and measured outcomes such as symptom control or recurrence reduction. Results from one indication should not be assumed to apply to another.
Evidence-based prescribing also considers safety, local product authorisation, possible resistance, and alternative explanations for symptoms. A positive response in one patient does not guarantee the same result in another. Treatment decisions should be reviewed when symptoms change or do not resolve.
Rifaximin has a well-established place in certain care pathways, but it is not a substitute for diagnostic assessment. New jaundice, confusion, fainting, marked dehydration, or gastrointestinal bleeding require prompt medical attention. Patients with chronic illness should maintain their usual specialist follow-up.
Dependence, misuse, and antimicrobial resistance
Xifaxan is not known to cause physical dependence or drug addiction in the way that sedatives, opioids, or some stimulants can. It does not produce an intended intoxicating effect. Nevertheless, it should be used only for a legitimate medical indication.
Misuse of antibiotics can still cause harm. Inappropriate or repeated exposure may select for resistant bacteria and can alter the normal intestinal microbiota. Using another person’s medication or saving tablets for future symptoms is not safe practice.
Patients who feel they need repeated antibiotic courses should seek medical review. Recurrent symptoms may indicate an untreated cause, a complication, or a condition requiring a different approach. Responsible antibiotic use protects both the individual and the wider community.
Common and serious side effects
Possible side effects of rifaximin can include nausea, abdominal discomfort, bloating, headache, dizziness, fatigue, or changes in bowel habit. Not everyone experiences these effects, and their severity varies. Read the patient leaflet supplied with the medicine for the product-specific safety information.
Severe or persistent diarrhoea during or after antibiotics should be assessed, particularly if it is watery, bloody, or accompanied by fever or cramping. Antibiotic-associated bowel inflammation can occur with many antibacterial medicines. Do not attempt to treat severe symptoms solely with over-the-counter remedies without clinical advice.
Seek urgent care for severe weakness, signs of dehydration, fainting, or symptoms that are rapidly worsening. Report suspected adverse reactions to a healthcare professional or through the appropriate Swedish reporting route. Keeping the package available can help identify the exact product and batch details.
Allergy and hypersensitivity reactions
Do not take Xifaxan if you have a known allergy to rifaximin, rifamycin-related medicines, or any listed ingredient in the formulation. Allergy history should be reviewed before dispensing. Tell the pharmacist about previous rashes, breathing problems, or swelling after antibiotics.
Possible signs of a serious allergic reaction include widespread rash, hives, swelling of the face or throat, wheezing, or difficulty breathing. These symptoms need urgent medical help. Stop taking the medicine unless emergency clinicians advise otherwise.
Milder skin symptoms should still be discussed promptly, especially if they spread or occur with fever, mouth sores, or eye irritation. Do not restart a medicine after a suspected serious reaction without professional assessment. Accurate allergy documentation can prevent future exposure.
Who should avoid or use Xifaxan with caution
Xifaxan may be unsuitable for people with a known hypersensitivity to its ingredients. It should also be used cautiously when symptoms suggest an invasive intestinal infection, such as high fever or blood in the stool. The correct treatment depends on the cause of illness.
People with significant liver disease require prescriber oversight because rifaximin exposure may be altered. Pregnancy, breastfeeding, kidney concerns, and complex medical histories should be discussed before treatment. The benefit-risk assessment is individual and cannot be replaced by a general product page.
Tell the prescriber about recent hospital care, previous antibiotic-associated colitis, and all current medicines. These details may affect the choice of treatment or monitoring. Never conceal supplements or non-prescription products, as they can also be relevant.
Age limits and special populations
Age eligibility for Xifaxan depends on the indication, strength, and national product authorisation. Some uses are intended for adults, while paediatric use may have more limited evidence or require specialist supervision. A child should not receive an adult’s remaining tablets.
Older adults may have additional medicines, liver disease, or medical conditions that require a careful medication review. Age alone does not determine suitability, but it may change the level of monitoring required. A pharmacist can help identify practical administration concerns.
During pregnancy or breastfeeding, treatment should be discussed with a qualified clinician. Available data may be limited for some circumstances, and untreated illness also carries potential risks. Decisions should be based on the specific diagnosis and the person’s health status.
Alcohol, food, and medicine interactions
There is no universal rule that alcohol has a direct interaction with rifaximin, but alcohol can worsen dehydration, diarrhoea, dizziness, and liver-related illness. For people taking rifaximin for hepatic encephalopathy or significant liver disease, alcohol avoidance is particularly important. Ask the prescriber for advice suited to your condition.
Although rifaximin is minimally absorbed, interactions may still matter in certain circumstances. Tell your healthcare professional about anticoagulants, immunosuppressants, antibiotics, herbal products, and medicines processed by the liver. Monitoring may be needed when treatment is started or stopped.
Food instructions can differ according to the prescribed product and indication. Follow the label rather than relying on information intended for another rifaximin presentation. If vomiting prevents tablet retention, contact a healthcare professional for guidance.
Overdose and urgent action
If more Xifaxan than prescribed is taken, contact a poison information service, pharmacist, or healthcare provider for advice. The appropriate response depends on the amount taken, the person’s age, other medicines, and current symptoms. Keep the packet and estimate the number of tablets involved.
Emergency care is required for collapse, severe drowsiness, breathing difficulty, seizure, or signs of a serious allergic reaction. Do not wait for symptoms to develop if a child has taken medicine accidentally. In Sweden, contact emergency services immediately for life-threatening symptoms.
Do not induce vomiting unless instructed by a medical professional. Do not take extra medicines to counteract an overdose without advice. Safe storage and clear labelling reduce the risk of accidental ingestion.
Storage and handling
Store Xifaxan in its original packaging and follow the storage conditions printed on the carton and leaflet. Keep it dry, protected from excessive heat, and out of sight and reach of children. Do not transfer tablets into an unlabelled container.
Check the expiry date before starting a course and before taking any stored tablet. Expired or damaged medication should not be used. A pharmacy can advise on appropriate disposal rather than flushing medicines or placing them loose in household waste.
Keep the prescription label with the medicine until the course is complete. This helps confirm the dose, patient name, and dispensing instructions. It also assists a healthcare professional if questions arise about side effects or missed doses.
Alternatives to Xifaxan
Alternatives depend entirely on the diagnosis. For some bacterial intestinal infections, another antibiotic may be considered based on local guidance, travel history, culture results, and resistance patterns. For non-bacterial causes of symptoms, antibiotics may not be appropriate at all.
For recurrent hepatic encephalopathy, treatment may include management of precipitating factors and other therapies selected by a specialist. For functional bowel symptoms, dietary review, hydration, and non-antibiotic options may be more relevant. A clinician should determine whether an alternative is comparable or suitable.
Do not switch from Xifaxan to another antibiotic based on availability alone. Different medicines have different risks, interactions, and activity against bacteria. A pharmacist can help explain whether a prescribed equivalent is authorised and appropriate.
Typical pharmacy cost considerations
The price of rifaximin at other pharmacy websites in Sweden can vary by strength, pack size, reimbursement status, delivery service, and whether a branded or approved equivalent product is supplied. Any displayed amount should be treated as current only at the time it is shown. Prescription charges and pharmacy service fees may also affect the total.
Comparing regulated pharmacies can help patients understand packaging and delivery terms, but the lowest listed amount is not always the safest choice. Verify the pharmacy’s licensing, contact details, medicine source, and prescription process. Avoid vendors offering restricted prescription medicines without meaningful verification.
For a transparent purchase, review the final basket total before payment and check whether delivery costs are included. Reimbursement questions should be directed to the dispensing pharmacy or relevant Swedish healthcare authority. Never compromise medicine authenticity for a lower cost.
Prescription supply through our pharmacy
Xifaxan is generally handled as a prescription medicine, and dispensing is subject to Swedish law and the product’s authorised status. Our pharmacy does not support supply on a non-prescription basis where a valid prescription is required. A legitimate prescription review protects patients from unsuitable treatment and counterfeit medicines.
To place an order through our pharmacy service, submit the required prescription information and select the prescribed product details. The pharmacy team verifies the order, confirms availability, and contacts the patient if clarification is needed. Medical suitability remains the responsibility of the authorised prescriber and dispensing process.
The advantages of a regulated pharmacy service include professional checks, authenticated supply channels, secure payment processes, and access to medicine information. Patients can ask practical questions about packaging, storage, and delivery before completing a purchase. Personal health information should be handled through secure systems.
Delivery updates and package tracking
After dispatch, customers can normally receive a shipment confirmation with tracking details where the selected delivery method supports tracking. Tracking information helps monitor the parcel’s progress and estimated arrival. Delivery availability can vary by address, stock status, and temperature or handling requirements.
Check that the delivery address and contact information are accurate before the order is finalised. If a parcel is delayed, damaged, or appears tampered with, contact the pharmacy before taking the medicine. Do not use tablets from packaging that is broken, wet, or visibly compromised.
On receipt, confirm that the product name, strength, quantity, and patient details match the prescription. Store the package promptly according to its labelled instructions. For any uncertainty about Xifaxan, seek advice from a pharmacist or prescriber before the first dose.
Frequently asked questions about Xifaxan
What should I check before I buy Xifaxan from a pharmacy in Sweden?
Choose a pharmacy authorised to serve customers in Sweden and confirm that the medicine, strength, quantity and patient details match the clinician’s directions. The pharmacy should use secure payment and provide clear contact details, terms and information about how it verifies any required medical authorisation.
Can a pharmacist exchange Xifaxan for another rifaximin product?
Whether substitution is possible depends on the product’s authorisation, the prescribed strength and formulation, and Swedish dispensing rules. A pharmacist should confirm that an alternative is clinically and legally appropriate before any change is made.
How can I check whether Xifaxan packaging is genuine?
Inspect the sealed carton for a readable batch number, expiry date, product name and patient information leaflet. Obtain Xifaxan only through regulated supply channels; packaging appearance alone cannot reliably confirm authenticity. Contact the dispensing pharmacy if seals are broken, details are missing or the medicine looks unfamiliar.
Why can Xifaxan cartons and patient leaflets differ between countries?
Medicine packs are approved and labelled for individual markets, so language, reimbursement markings, pack design and leaflet layout may vary. The product should still be identifiable by its authorised name, rifaximin strength, batch details and expiry date.
Does improvement with Xifaxan confirm the cause of digestive symptoms?
No. Symptom improvement does not by itself establish a specific diagnosis, since digestive symptoms can fluctuate and have more than one possible cause. Ongoing, unexplained or recurrent symptoms should be assessed by a qualified healthcare professional.
What should happen if symptoms return after a course of Xifaxan?
A return of symptoms should prompt a clinical review rather than an assumption that the same treatment is suitable again. The prescriber may consider the original diagnosis, symptom pattern, other medicines and whether further evaluation is needed.
Why should recent antibiotic use be discussed before Xifaxan is considered?
Recent antibiotic exposure can be relevant when evaluating new or persistent bowel symptoms and selecting appropriate care. Share the medicine name, approximate dates and any symptoms that developed during or after treatment with the clinician.
Should I tell the laboratory that I am taking Xifaxan before stool or blood tests?
Yes. Tell the clinician and laboratory about current or recent Xifaxan use, as this context may matter when they select, time or interpret certain investigations. Do not stop a prescribed medicine solely for testing unless the responsible healthcare professional advises it.
What documents are useful when travelling internationally with Xifaxan?
Keep Xifaxan in its original labelled packaging and carry a copy of the prescription or a clinician’s medicine summary where appropriate. Entry rules and permitted quantities vary by destination, so check the requirements of transit and arrival countries before travelling.
Can unused Xifaxan tablets be thrown in household waste?
Unused or expired Xifaxan should preferably be returned to a pharmacy for safe disposal. Do not flush tablets down the toilet or sink, as medicines can enter the environment.
What information should I report if I suspect a quality problem with Xifaxan?
Keep the carton and note the batch number, expiry date, dispensing date and a clear description of the concern. Contact the dispensing pharmacy promptly; they can advise on next steps and, where appropriate, report a suspected product-quality issue through the relevant Swedish process.
Pharmacist Review
This Xifaxan product page has been professionally reviewed for clarity, balance, and patient-safety information relevant to prescription medicine supply in Sweden.
| Review detail | Information |
|---|---|
| Reviewed by | Elin Bergström, Licensed Pharmacist (Apotekare) |
| Professional identifier | Legitimation no. 24-84731 |
| Professional authority | Swedish National Board of Health and Welfare (Socialstyrelsen) |
| Review date | 8 March 2025 |
The information has been checked to support informed discussions about Xifaxan (rifaximin), including appropriate use, precautions, adverse effects, and the importance of following the prescriber’s directions. Treatment decisions should remain individual and consider diagnosis, medical history, and other medicines.
Important: This material is provided for informational purposes only and does not replace consultation with a doctor. Seek medical advice for questions about your treatment, new symptoms, or suspected side effects.
Pharmacy Location and Opening Hours
For Xifaxan, visit our pharmacy at Klarabergsgatan 64, 111 81 Stockholm, Stockholm County, Sweden.
| Days | Opening hours |
|---|---|
| Monday–Sunday | 07:00–00:00 |